Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Wockhardt Limited
Press Release Jun 28 2024
Business
Jun 28 2024
5 min read

Press Release Jun 28 2024

Wockhardt Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled "Globally renowned US body Clinical and Laboratory Standards Institute (CLSI) awards high susceptibility breakpoints to Zaynich (Zidebactam/Cefepime- WCK 5222)".

View Attachment